Lang J C, Spandidos D A
Anticancer Res. 1986 May-Jun;6(3 Pt B):437-49.
Transcriptional enhancers have now been identified near or within a large number of viral and cellular genes. They are cis-acting regulatory sequences generally capable of elevating transcription from a linked gene in a distance and orientation independent manner. More recent evidence suggests that this activity may be modulated in a host-cell-specific manner. Enhancer function in some cases at least appears to be controlled by the operation of trans-acting factors within the host cell. Occasionally enhancers may also be responsible for repression of gene transcription. It has now become clear that the development of some cancers may be linked with the activity of enhancer sequences. It is likely that this process involves subversion of the normal regulatory mechanisms which control expression of proto-oncogenes through the interposition of exogenous, cis-acting enhancer sequences. The evidence comes from two sources, firstly a strong association between the action of enhancer sequences and some forms of naturally occurring cancers, and secondly, the induction of neoplastic transformation in susceptible cells by genetically manipulated oncogenes under the transcriptional control of enhancer elements.
转录增强子现已在大量病毒和细胞基因附近或内部被发现。它们是顺式作用的调控序列,通常能够以距离和方向独立的方式提高相连基因的转录水平。最近的证据表明,这种活性可能以宿主细胞特异性的方式受到调节。至少在某些情况下,增强子功能似乎受宿主细胞内反式作用因子的调控。偶尔,增强子也可能导致基因转录的抑制。现已明确,某些癌症的发生可能与增强子序列的活性有关。这个过程可能涉及正常调控机制的颠覆,即通过插入外源性顺式作用增强子序列来控制原癌基因的表达。证据来自两个方面,首先是增强子序列的作用与某些自然发生的癌症形式之间存在强烈关联,其次是在增强子元件的转录控制下,经基因操作的癌基因在易感细胞中诱导肿瘤转化。